← Leaderboards
Tamsin Kate Phillips
University Of Cape Town
$597,527
Attributed
$597,527
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $200K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$597,527 · 1
By mechanism
K43$597,527 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cape Town
Same institution · by research overlap
- Jo-Ann Shelley Passmore$969,370
- Andrew Marc Boulle$3,518,528
- Linda-Gail Bekker$40,471,276
- Graeme Ayton Meintjes$3,614,424
- Mark Hatherill$4,643,241
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignEffectiveness Of InterventionsAfrica South Of The SaharaAdherenceAcquired Immunodeficiency SyndromeEffectivenessAntiretroviral TherapyAreaAttentionAftercareAdultBehavioralAids PreventionBehavioral EconomicsBehavioral ResearchBehavior MeasurementCareerCareer DevelopmentCaringClinicCommunitiesAwardContraceptive AgentsEmpowerment
Grant awards (6)
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$107,001
K43 · FY2025 · TW · contact PI
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$104,642
K43 · FY2024 · TW · contact PI
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$95,404
K43 · FY2024 · TW · contact PI
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$100,585
K43 · FY2023 · TW · contact PI
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$96,766
K43 · FY2022 · TW · contact PI
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa$93,129
K43 · FY2021 · TW · contact PI